VYOME HOLDINGS, INC. Increase (Decrease) in Contract with Customer, Liability
VYOME HOLDINGS, INC. (HIND) reported Increase (Decrease) in Contract with Customer, Liability of $0 for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-05-12
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-12-31 was -$61.00K, a 143.26% decline year-over-year.
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-09-30 was -$61.00K.
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for the quarter ending 2020-06-30 was -$340.00K.
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for fiscal 2020 was -$424.00K, a 688.89% decline from fiscal 2019.
- VYOME HOLDINGS, INC. increase (decrease) in contract with customer, liability for fiscal 2019 was $72.00K.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-12 | -$61.00K derived: sum of 2 quarters · filed 2021-05-12 | -$122.00K derived: sum of 3 quarters · filed 2021-05-12 | -$462.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-12-31 | -$61.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | -$122.00K derived: sum of 2 quarters · filed 2021-03-12 | -$462.00K derived: sum of 3 quarters · filed 2021-03-12 | -$424.00K 10-K · filed 2021-03-12 |
| 2020-09-30 | -$61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$401.00K derived: sum of 2 quarters · filed 2020-11-06 | -$363.00K 10-Q · filed 2020-11-06 | -$222.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-06-30 | -$340.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$302.00K 10-Q · filed 2020-07-30 | -$161.00K derived: sum of 3 quarters · filed 2021-05-12 | -$198.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2020-03-31 | $38.00K 10-Q · filed 2021-05-12 | $179.00K derived: sum of 2 quarters · filed 2021-05-12 | $142.00K derived: sum of 3 quarters · filed 2021-05-12 | $92.00K derived: sum of 4 quarters · filed 2021-05-12 |
| 2019-12-31 | $141.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $104.00K derived: sum of 2 quarters · filed 2021-03-12 | $54.00K derived: sum of 3 quarters · filed 2021-03-12 | $72.00K 10-K · filed 2021-03-12 |
| 2019-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$87.00K derived: sum of 2 quarters · filed 2020-11-06 | -$69.00K 10-Q · filed 2020-11-06 | |
| 2019-06-30 | -$50.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | -$32.00K 10-Q · filed 2020-07-30 | ||
| 2019-03-31 | $18.00K 10-Q · filed 2020-06-19 | |||
| 2018-09-30 | -$1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | -$36.00K derived: sum of 2 quarters · filed 2019-11-08 | -$209.00K 10-Q · filed 2019-11-08 | |
| 2018-06-30 | -$35.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | -$208.00K 10-Q · filed 2019-07-24 | ||
| 2018-03-31 | -$173.00K 10-Q · filed 2019-05-10 | |||
| 2017-09-30 | -$13.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $72.00K 10-Q · filed 2018-11-02 | ||
| 2017-06-30 | $85.00K 10-Q · filed 2018-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |